Search

Your search keyword '"Hesse C"' showing total 12 results
Start Over Author "Hesse C" Journal transplantation proceedings
12 results on '"Hesse C"'

3. Evaluation of the new EMIT enzyme immunoassay for the determination of whole-blood tacrolimus concentrations in kidney, heart, and liver transplant recipients.

Author

Hesse CJ, Baan CC, Balk AH, Metselaar HJ, Weimar W, and van Gelder T

Subjects
Blood Specimen Collection methods, Drug Monitoring methods, Humans, Immunosuppressive Agents blood, Immunosuppressive Agents pharmacokinetics, Immunosuppressive Agents therapeutic use, Metabolic Clearance Rate, Quality Control, Tacrolimus pharmacokinetics, Tacrolimus therapeutic use, Enzyme Multiplied Immunoassay Technique standards, Heart Transplantation physiology, Kidney Transplantation physiology, Liver Transplantation physiology, Tacrolimus blood
Published
2002
Full Text
View/download PDF

4. The value of routine monitoring of mycophenolic acid plasma levels after clinical heart transplantation.

Author

Hesse CJ, Vantrimpont P, van Riemsdijk-van Overbeeke IC, van Gelder T, Balk AH, and Weimar W

Subjects
Acute Disease, Biopsy, Cyclosporine adverse effects, Cyclosporine blood, Drug Monitoring, Follow-Up Studies, Graft Rejection blood, Heart Transplantation immunology, Heart Transplantation pathology, Humans, Immunosuppressive Agents therapeutic use, Mycophenolic Acid analogs & derivatives, Tacrolimus therapeutic use, Time Factors, Cyclosporine therapeutic use, Heart Transplantation physiology, Immunosuppressive Agents pharmacokinetics, Mycophenolic Acid blood, Mycophenolic Acid pharmacokinetics, Mycophenolic Acid therapeutic use
Published
2001
Full Text
View/download PDF

5. Relation of mycophenolic acid trough levels and adverse events in kidney allograft recipients.

Author

Smak Gregoor PJ, Hesse CJ, van Gelder T, van der Mast BJ, IJzermans JN, van Besouw NM, and Weimar W

Subjects
Azathioprine therapeutic use, Cyclosporine therapeutic use, Drug Therapy, Combination, Glomerular Filtration Rate drug effects, Graft Rejection pathology, Graft Rejection prevention & control, Humans, Immunosuppressive Agents therapeutic use, Kidney Transplantation physiology, Mycophenolic Acid blood, Mycophenolic Acid therapeutic use, Prednisolone therapeutic use, Retrospective Studies, Transplantation, Homologous, Graft Rejection drug therapy, Immunosuppressive Agents adverse effects, Immunosuppressive Agents pharmacokinetics, Kidney Transplantation immunology, Mycophenolic Acid adverse effects, Mycophenolic Acid analogs & derivatives, Mycophenolic Acid pharmacokinetics
Published
1998
Full Text
View/download PDF

6. Peripheral blood monitoring during and after rejection-prophylaxis with a monoclonal anti-interleukin-2-receptor antibody in kidney and heart transplant recipients.

Author

van Gelder T, Knoop CJ, Hesse CJ, Vaessen LM, Balk AH, Yzermans JN, and Weimar W

Subjects
Cyclosporine therapeutic use, Drug Monitoring, Humans, Immunosuppression Therapy, Radioimmunoassay, T-Lymphocyte Subsets immunology, Transplantation, Homologous, Antibodies, Monoclonal blood, Antibodies, Monoclonal therapeutic use, Antigens, CD blood, Graft Rejection prevention & control, Heart Transplantation immunology, Kidney Transplantation immunology, Receptors, Interleukin-2 immunology
Published
1995

7. The incidence and quantity of antiidiotypic antibody formation after OKT3 monoclonal therapy in heart-transplant recipients.

Author

Hesse CJ, Heyse P, Stolk BJ, Balk AH, Jutte NH, Mochtar B, and Weimar W

Subjects
Antibodies, Monoclonal immunology, Azathioprine therapeutic use, Combined Modality Therapy, Cyclosporins therapeutic use, Enzyme-Linked Immunosorbent Assay, Fluorescent Antibody Technique, Humans, Muromonab-CD3, Prednisone therapeutic use, Transplantation, Homologous, Antibodies, Anti-Idiotypic analysis, Antibodies, Monoclonal therapeutic use, Heart Transplantation immunology, Immunosuppression Therapy
Published
1990

10. Differences in antibody formation to OKT3 between kidney and heart transplantation recipients.

Author

Hesse CJ, Heyse P, Stolk BJ, Hendriks GF, Weimar W, Balk AH, Mochtar B, and Jutte NH

Subjects
Combined Modality Therapy, Humans, Immunoglobulin G analysis, Immunoglobulin M analysis, Immunosuppressive Agents therapeutic use, Immunotherapy, Transplantation, Homologous, Antibodies, Monoclonal therapeutic use, Antibody Formation, Heart Transplantation, Kidney Transplantation
Published
1989

11. The prophylactic use of Orthoclone OKT3 in kidney and heart transplantation.

Author

Weimar W, Baumgartner D, Hendriks GF, Hesse CJ, Balk AH, Simoons ML, and Bos E

Subjects
Antibodies, Monoclonal adverse effects, Antibodies, Monoclonal toxicity, Azathioprine therapeutic use, Follow-Up Studies, Graft Rejection, Humans, Muromonab-CD3, Antibodies, Monoclonal therapeutic use, Heart Transplantation, Kidney Transplantation
Published
1988

12. The effect of azathioprine on the generation of passive enhancing sera.

Author

Diderich PP, Bonthuis F, Hesse CJ, Vaessen LM, and Lameijer LD

Subjects
Animals, Antibody Formation, Polyethylene Glycols pharmacology, Rats, Transplantation, Homologous, Antigen-Antibody Complex, Azathioprine pharmacology, Graft Survival drug effects, Kidney Transplantation
Published
1979

Catalog

Books, media, physical & digital resources
See catalog results